 | Up a level |
Feuchtinger, Annette; Stiehler, Tabitha; Jütting, Uta; Marjanovic, Goran; Luber, Birgit; Langer, Rupert; Walch, Axel (2015). Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma. Histochemistry and cell biology, 143(1), pp. 1-9. Springer 10.1007/s00418-014-1258-2
Aichler, Michaela; Motschmann, Martin; Jütting, Uta; Luber, Birgit; Becker, Karen; Ott, Katja; Lordick, Florian; Langer, Rupert; Feith, Marcus; Siewert, Jörg Rüdiger; Walch, Axel (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. OncoTarget, 5(16), pp. 6620-6632. Impact Journals LLC
Elsner, Mareike; Rauser, Sandra; Maier, Stefan; Schöne, Cédrik; Balluff, Benjamin; Meding, Stephan; Jung, Gerhard; Nipp, Martin; Sarioglu, Hakan; Maccarrone, Giuseppina; Aichler, Michaela; Feuchtinger, Annette; Langer, Rupert; Jütting, Uta; Feith, Marcus; Küster, Bernhard; Ueffing, Marius; Zitzelsberger, Horst; Höfler, Heinz and Walch, Axel (2012). MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. Journal of proteomics, 75(15), pp. 4693-704. Amsterdam: Elsevier 10.1016/j.jprot.2012.02.012
